An evidence-based cost-effectiveness model on methods of prevention of posttraumatic venous thromboembolism - Editorial comment

被引：0
|
作者：
Owings, JT [1 ]
机构：
[1] Univ Calif Davis, Sacramento, CA 95817 USA
来源：
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE | 2000年 / 49卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1064 / 1064
页数：1
相关论文
共 50 条
  • [21] Suicide Prevention, Part 2: Evidence-Based Practices, Cost-Effectiveness, and Future Directions
    Goldman, Matthew L.
    Dixon, Lisa B.
    PSYCHIATRIC SERVICES, 2020, 71 (12) : 1320 - 1321
  • [22] Postpartum venous thromboembolism prophylaxis: A Cost-Effectiveness Analysis
    Becker, David A.
    Einerson, Brett D.
    Wetta, Luisa L.
    Kuper, Spencer G.
    Casey, Brian M.
    Subramaniam, Akila
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (01) : S487 - S488
  • [23] Evidence-based medicine meets cost-effectiveness analysis
    Clancy, CM
    Kamerow, DB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (04): : 329 - 330
  • [24] Cost-Effectiveness Analysis: A Component of Evidence-Based Education
    Detrich, Ronnie
    SCHOOL PSYCHOLOGY REVIEW, 2020, 49 (04) : 423 - 430
  • [25] Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in China
    Xiaoyu Yan
    Xiaohua Gu
    Zhenxing Xu
    Houweng Lin
    Bin Wu
    Advances in Therapy, 2017, 34 : 466 - 480
  • [26] COST-EFFECTIVENESS OF DIFFERENT STRATEGIES FOR PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT IN CHINA
    Yan, X. Y.
    Gu, X. H.
    Zhou, L.
    Lin, H. W.
    Wu, B.
    VALUE IN HEALTH, 2016, 19 (07) : A866 - A866
  • [27] Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: A US perspective
    Seaman, Craig D.
    Smith, Kenneth J.
    Ragni, Margaret V.
    THROMBOSIS RESEARCH, 2013, 132 (06) : 647 - 651
  • [28] COST-EFFECTIVENESS OF APIXABAN COMPARED TO OTHER ANTICOAGULANTS FOR LIFETIME TREATMENT AND PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM
    Lanitis, T.
    Hamilton, M.
    Rublee, D. A.
    Leipold, R.
    Quon, P.
    Browne, C.
    Cohen, A. T.
    VALUE IN HEALTH, 2014, 17 (07) : A488 - A488
  • [29] Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients
    Fowler, Robert A.
    Mittmann, Nicole
    Geerts, William
    Heels-Ansdell, Diane
    Gould, Michael K.
    Guyatt, Gordon
    Krahn, Murray
    Finfer, Simon
    Pinto, Ruxandra
    Chan, Brian
    Ormanidhi, Orges
    Arabi, Yaseen
    Qushmaq, Ismael
    Rocha, Marcelo G.
    Dodek, Peter
    McIntyre, Lauralyn
    Hall, Richard
    Ferguson, Niall D.
    Mehta, Sangeeta
    Marshall, John C.
    Doig, Christopher James
    Muscedere, John
    Jacka, Michael J.
    Klinger, James R.
    Vlahakis, Nicholas
    Orford, Neil
    Seppelt, Ian
    Skrobik, Yoanna K.
    Sud, Sachin
    Cade, John F.
    Cooper, Jamie
    Cook, Deborah
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (20): : 2135 - 2145
  • [30] COST-EFFECTIVENESS OF APIXABAN AND ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENT IN CHINA
    Yan, X. Y.
    Gu, X. H.
    Bu, J.
    Lin, H. W.
    Wu, B.
    VALUE IN HEALTH, 2016, 19 (07) : A651 - A651
12345